Cite
MLA Citation
A Goldman et al.. “The real-world safety profile of SGLT2 inhibitors among adults 75 years or older: a retrospective, pharmacovigilance study.” European heart journal, vol. 43, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100168329503.0x00002c